Management and Antiretroviral Treatment of HIV Infection
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Medical Microbiology".
Deadline for manuscript submissions: closed (31 July 2021) | Viewed by 1871
Special Issue Editors
Interests: HIV infection; HIV treatment and prevention
Special Issue Information
Dear Colleagues,
Antiretroviral therapy (ART) has dramatically changed the prognosis of HIV infection. Nowadays, people living with HIV (PLWH) have a life expectancy similar to that of the general population, and aging-related comorbidities are increasingly common in PLWH. However, PLWH must take ART for decades, and this may negatively affect their adherence to the therapy and consequently impair the efficacy of the treatment. In addition, long-term ART-related toxicities, although infrequent, are observed.
The primary goal of the management of HIV infection remains the achievement of viral suppression, with its beneficial consequences that include immune system restoration, prevention of disease progression, and breaking of the chain of transmission. However, to reach this target, new strategies and drug classes (e.g., two-drug regimens, attachment and capsid inhibitors) and new drug formulation (e.g., long-acting injectables) are needed.
For this Special Issue of Microorganisms, dedicated to the management and antiretroviral treatment of HIV infection, we invite you to send your contributions concerning any aspects related to this essential topic.
In fact, although HIV research has made significant progress, we believe that there are still unmet needs requiring more study and discussion. This Special Issue could be a great opportunity to clear up all main debated points.
Dr. Vincenzo Spagnuolo
Dr. Camilla Muccini
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HIV infection
- antiretroviral therapy
- HIV management
- virological response
- drug toxicity
- adherence
- novel therapeutic strategies
